Insider · CIK 0001940536
Sarah Gilligan
Files at GAP (GAP INC), CMRC (BigCommerce Holdings, Inc.). First filing Mar 17, 2025, latest Mar 20, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GAP: GAP INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | GAP INC | $71k 3,644 shares | -100% | - | |
| 22Weak | GAP INC | $52k 2,634 shares | -100% | - | |
| 34Weak | GAP INC | $607k 29,813 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | CMRC BigCommerce Holdings, Inc. | AGrant or award Series 1 Common Stock | +2,320 | $0.00 | $0 | 75,835 | Jun 9, 2025 |
| Jun 5, 2025 | CMRC BigCommerce Holdings, Inc. | AGrant or award Series 1 Common Stock | +34,337 | $0.00 | $0 | 110,172 | Jun 9, 2025 |
| Mar 19, 2025 | GAP GAP INC | SOpen-market sale Common Stock10b5-1 | -3,644 | $19.47 | $71k | 0 | Mar 20, 2025 |
| Mar 17, 2025 | GAP GAP INC | SOpen-market sale Common Stock10b5-1 | -1,830 | $20.00 | $37k | 804 | Mar 18, 2025 |
| Mar 18, 2025 | GAP GAP INC | MOption exercise Common Stock10b5-1 | +7,403 | $0.00 | $0 | 8,207 | Mar 18, 2025 |
| Mar 18, 2025 | GAP GAP INC | FTax withholding Common Stock10b5-1 | -3,759 | $20.10 | $76k | 4,448 | Mar 18, 2025 |
| Mar 18, 2025 | GAP GAP INC | SOpen-market sale Common Stock10b5-1 | -804 | $19.59 | $16k | 3,644 | Mar 18, 2025 |
| Mar 17, 2025 | GAP GAP INC | AGrant or award Restricted Stock Unitderivative10b5-1 | +33,914 | $0.00 | $0 | 88,397 | Mar 18, 2025 |
| Mar 18, 2025 | GAP GAP INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -7,403 | $0.00 | $0 | 80,994 | Mar 18, 2025 |
| Mar 14, 2025 | GAP GAP INC | SOpen-market sale Common Stock10b5-1 | -29,813 | $20.34 | $607k | 0 | Mar 17, 2025 |
| Mar 14, 2025 | GAP GAP INC | MOption exercise Common Stock10b5-1 | +3,439 | $0.00 | $0 | 3,439 | Mar 17, 2025 |
| Mar 14, 2025 | GAP GAP INC | FTax withholding Common Stock10b5-1 | -1,609 | $20.76 | $33k | 1,830 | Mar 17, 2025 |
| Mar 15, 2025 | GAP GAP INC | MOption exercise Common Stock10b5-1 | +1,633 | $0.00 | $0 | 3,463 | Mar 17, 2025 |
| Mar 15, 2025 | GAP GAP INC | FTax withholding Common Stock10b5-1 | -829 | $20.13 | $17k | 2,634 | Mar 17, 2025 |
| Mar 14, 2025 | GAP GAP INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -3,439 | $0.00 | $0 | 56,116 | Mar 17, 2025 |
| Mar 15, 2025 | GAP GAP INC | MOption exercise Restricted Stock Unitderivative10b5-1 | -1,633 | $0.00 | $0 | 54,483 | Mar 17, 2025 |
| Mar 13, 2025 | GAP GAP INC | MOption exercise Common Stock | +10,714 | $0.00 | $0 | 10,714 | Mar 14, 2025 |
| Mar 13, 2025 | GAP GAP INC | FTax withholding Common Stock | -3,837 | $21.03 | $81k | 6,877 | Mar 14, 2025 |
| Mar 13, 2025 | GAP GAP INC | MOption exercise Common Stock | +35,714 | $0.00 | $0 | 42,591 | Mar 14, 2025 |
| Mar 13, 2025 | GAP GAP INC | FTax withholding Common Stock | -12,778 | $21.03 | $269k | 29,813 | Mar 14, 2025 |
| Mar 13, 2025 | GAP GAP INC | MOption exercise Restricted Stock Unitderivative | -10,714 | $0.00 | $0 | 95,269 | Mar 14, 2025 |
| Mar 13, 2025 | GAP GAP INC | MOption exercise Restricted Stock Unitderivative | -35,714 | $0.00 | $0 | 59,555 | Mar 14, 2025 |
| Feb 27, 2025 | CMRC BigCommerce Holdings, Inc. | AGrant or award Series 1 Common Stock | +1,746 | $0.00 | $0 | 73,515 | Mar 3, 2025 |
| Nov 21, 2024 | CMRC BigCommerce Holdings, Inc. | AGrant or award Series 1 Common Stock | +1,966 | $0.00 | $0 | 71,769 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.